Abstract:
A culture method for pluripotent stem cells includes culturing pluripotent stem cells on a cell culture surface of a support by using a medium in which the concentration of 2-mercaptoethano is equal to or less than 10 μM in the presence of a polypeptide consisting of 40 to 450 amino acid residues, in which the polypeptide includes (1) a first domain including at least one amino acid sequence selected from the group consisting of an amino acid sequence represented by CSYYQSC (SEQ ID NO: 1) and an amino acid sequence represented by RGD and (2) a second domain including (2-i) an amino acid sequence which is represented by PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN (SEQ ID NO: 2), (2-ii) an amino acid sequence which shares sequence identity of equal to or higher than 50% with the amino acid sequence represented by SEQ ID NO: 2 and exhibits adsorbability with respect to the cell culture surface of the support, or (2-iii) an amino acid sequence which is formed by the addition, substitution, or deletion of 1 to 30 amino acids in the amino acid sequence represented by SEQ ID NO: 2 and exhibits adsorbability with respect to the cell culture surface of the support.
Abstract translation:多能干细胞的培养方法包括通过使用其中2-巯基乙醇的浓度等于或小于10μM的培养基,在多肽组成的培养基中培养多能干细胞,所述多肽由40〜 450个氨基酸残基,其中多肽包括(1)包含至少一个选自由CSYYQSC(SEQ ID NO:1)表示的氨基酸序列的氨基酸序列的氨基酸序列的第一结构域和由 RGD和(2)包含(2-i)由PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN(SEQ ID NO:2)表示的氨基酸序列的第二结构域,(2-ii)具有等于或高于 50%与SEQ ID NO:2表示的氨基酸序列相比,表现出对载体的细胞培养表面的吸附性,或(2-iii)通过添加,取代或取代形成的氨基酸序列 在SEQ ID NO:2所示的氨基酸序列中为1〜30个氨基酸,并且相对于载体的细胞培养物表面具有吸附性。
Abstract:
A polypeptide including: (1) a first region containing at least one selected from the group consisting of an amino acid sequence represented by CSYYQSC (SEQ ID NO:1) and an amino acid sequence represented by RGD; and (2) a second region containing (2-i) an amino acid sequence represented by PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN (SEQ ID NO:2), (2-ii) an amino acid sequence having an identity of not less than 50% to the amino acid sequence represented by SEQ ID NO:2 and having an adsorption ability to a cultivation container, or (2-iii) an amino acid sequence that is the amino acid sequence represented by SEQ ID NO:2 in which from 1 to 30 amino acid residues are added, substituted, or deleted, and has an adsorption ability to a cultivation container, in which the polypeptide includes from 40 to 450 amino acid residues.
Abstract translation:一种多肽,包括:(1)含有选自由CSYYQSC(SEQ ID NO:1)表示的氨基酸序列和由RGD表示的氨基酸序列组成的组中的至少一种的第一区域; 和(2)含有(2-i)由PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN(SEQ ID NO:2)表示的氨基酸序列的第二区域,(2-ii)与氨基酸具有不小于50%的同一性的氨基酸序列 由SEQ ID NO:2表示的具有对培养容器的吸附能力的序列,或(2-iii)作为SEQ ID NO:2所示的氨基酸序列的氨基酸序列,其中含有1〜30个氨基酸残基 被添加,取代或缺失,并且对培养容器具有吸附能力,其中多肽包含40至450个氨基酸残基。
Abstract:
A culture method for pluripotent stem cells includes obtaining a polypeptide-coated culture surface by applying a polypeptide to a cell culture surface of a support, and culturing pluripotent stem cells by seeding the pluripotent stem cells onto the polypeptide-coated culture surface by using a medium in which the content of an ascorbic acid derivative is equal to or greater than 1.5 mmol/L (mM), in which the polypeptide is (a) a polypeptide having an amino acid sequence represented by SEQ ID NO: 1, (b) a polypeptide having an amino acid sequence, which shares identity of equal to or higher than 80% with the amino acid sequence represented by SEQ ID NO: 1, and having culture performance for pluripotent stem cells, or (c) a polypeptide having an amino acid sequence, which is formed by the deletion, substitution, or addition of one amino acid or several amino acids in SEQ ID NO: 1, and having culture performance for pluripotent stem cells.
Abstract translation:多能干细胞的培养方法包括通过将多肽施用于载体的细胞培养物表面获得多肽包被的培养物表面,并通过使用培养基将多能干细胞接种到多肽包被的培养物表面上来培养多能干细胞 其中抗坏血酸衍生物的含量等于或大于1.5mmol / L(mM),其中多肽是(a)具有SEQ ID NO:1所示氨基酸序列的多肽,(b)a 具有氨基酸序列的多肽,其与SEQ ID NO:1所示的氨基酸序列具有等于或高于80%的同一性,并具有多能干细胞的培养性能,或(c)具有氨基酸的多肽 序列,其通过SEQ ID NO:1中的一个氨基酸或几个氨基酸的缺失,取代或添加而形成,并具有多能干细胞的培养性能。
Abstract:
A polypeptide including: (1) a first region containing at least one selected from the group consisting of an amino acid sequence represented by CSYYQSC (SEQ ID NO:1) and an amino acid sequence represented by RGD; and (2) a second region containing (2-i) an amino acid sequence represented by PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN (SEQ ID NO:2), (2-ii) an amino acid sequence having an identity of not less than 50% to the amino acid sequence represented by SEQ ID NO:2 and having an adsorption ability to a cultivation container, or (2-iii) an amino acid sequence that is the amino acid sequence represented by SEQ ID NO:2 in which from 1 to 30 amino acid residues are added, substituted, or deleted, and has an adsorption ability to a cultivation container, in which the polypeptide includes from 40 to 450 amino acid residues.
Abstract translation:一种多肽,包括:(1)含有选自由CSYYQSC(SEQ ID NO:1)表示的氨基酸序列和由RGD表示的氨基酸序列组成的组中的至少一种的第一区域; 和(2)含有(2-i)由PRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQN(SEQ ID NO:2)表示的氨基酸序列的第二区域,(2-ii)与氨基酸具有不小于50%的同一性的氨基酸序列 由SEQ ID NO:2表示的具有对培养容器的吸附能力的序列,或(2-iii)作为SEQ ID NO:2所示的氨基酸序列的氨基酸序列,其中含有1〜30个氨基酸残基 被添加,取代或缺失,并且对培养容器具有吸附能力,其中多肽包含40至450个氨基酸残基。
Abstract:
An object of the present invention is to provide an anti-tumor agent and an anti-tumor kit which have superior anti-tumor effect as compared with a therapy with gemcitabine, paclitaxel or a combination thereof; as well as an anti-tumor effect enhancer. According to the present invention, provided is an anti-tumor agent including paclitaxel or a salt thereof and 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine or a salt or prodrug thereof.
Abstract:
An object of the present invention is to provide lipid particles which have low cytotoxicity, can stably hold nucleic acid molecules outside cells, and can promptly release nucleic acids in cytoplasm after escaping from endosome, and a nucleic acid delivery carrier. According to the present invention, there are provided lipid particles containing a compound represented by the following General Formula (1), sterol, at least one lipid selected from the group consisting of a neutral lipid and a lipid having a polyethylene glycol chain, and nucleic acids, and a nucleic acid delivery carrier. In the formula, R1 and R2 are the same as or different from each other, and are alkyl groups having 10 to 22 carbon atoms.
Abstract:
A polypeptide composition induces a pluripotent stem cell culturing property, particularly, an excellent cell growth ability. The polypeptide composition contains a predetermined polypeptide including an amino acid sequence of human vitronectin or an amino acid sequence of a predetermined first region derived from human vitronectin. The polypeptide composition includes a multimeric polypeptide, which is composed of two or more monomers held together by intermolecular cross-linking via cysteine residues included in the first region, in an amount equal to or less than 20% by mass of a total mass of polypeptides contained in the composition. A culture method for pluripotent stem cells includes culturing pluripotent stem cells in the presence of the polypeptide composition. Also provided is a culture vessel including a support which has a cell culture surface and the polypeptide contained in the polypeptide composition disposed on the cell culture surface of the support.